Bendamustine in combination with rituximab (BR) for patients with relapsed chronic lymphocytic leukemia (CLL): A multicentre phase II trail of the German CLL Study Group (GCLLSG).

被引：6

作者：

Fischer, Kirsien ^{[1
]}

Stilgenbauer, Stephan ^{[2
]}

Schweighofer, Carmen D. ^{[1
]}

Renschler, Jasmin ^{[1
]}

Busch, Raymonde ^{[3
]}

Kiehl, Michael ^{[4
]}

Balleisen, Leopold ^{[5
]}

Eckart, Michael ^{[6
]}

Fink, Anna M. ^{[1
]}

Boettcher, Sebastian ^{[7
]}

Ritgen, Matthias ^{[7
]}

Kneba, Michael ^{[7
]}

Staib, Peter ^{[1
]}

Doehner, Hartmut ^{[2
]}

Eichhorst, Barbara F. ^{[1
]}

Hallek, Michael ^{[1
]}

机构：

[1] Univ Hosp, Dept Internal Med 1, Cologne, Germany

[2] Univ Hosp, Dept Internal Med, Ulm, Germany

[3] Tech Univ, Inst Med Stat & Epidemiol, Munich, Germany

[4] Hospital, Dept Internal Med, Frankfurt, Germany

[5] Hospital, Dept Internal Med, Hamm, Germany

[6] ISP Naegelsbacherstr, Erlangen, Germany

[7] Univ Hosp, Dept Internal Med, Kiel, Germany

来源：

关键词：

D O I：

10.1182/blood.V110.11.3106.3106

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3106

引用

页码：913A / 914A

页数：2